vs
ACRES Commercial Realty Corp.(ACR)与太平洋生物科学(ASMB)财务数据对比。点击上方公司名可切换其他公司
ACRES Commercial Realty Corp.的季度营收约是太平洋生物科学的1.9倍($20.0M vs $10.8M),ACRES Commercial Realty Corp.净利率更高(31.6% vs -85.2%,领先116.9%),太平洋生物科学同比增速更快(57.6% vs -6.5%)
皮拉马尔地产是一家印度房地产企业,2012年成立,总部位于印度孟买,隶属于皮拉马尔集团。公司专注于住宅及商业地产开发,目前在手开发项目总规模约达1500万平方英尺,知名项目包括Piramal Aranya、Piramal Mahalaxmi等。
该公司是一家成立于2004年的美国生物科技企业,主要研发生产基因测序相关设备,同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台,分别是基于零模波导特性的单分子实时测序平台,以及结合天然核苷酸无痕连接技术的结合测序平台。
ACR vs ASMB — 直观对比
营收规模更大
ACR
是对方的1.9倍
$10.8M
营收增速更快
ASMB
高出64.1%
-6.5%
净利率更高
ACR
高出116.9%
-85.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $20.0M | $10.8M |
| 净利润 | $6.3M | $-9.2M |
| 毛利率 | — | — |
| 营业利润率 | 30.8% | -100.9% |
| 净利率 | 31.6% | -85.2% |
| 营收同比 | -6.5% | 57.6% |
| 净利润同比 | -32.0% | 4.3% |
| 每股收益(稀释后) | $-0.41 | $-0.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACR
ASMB
| Q4 25 | $20.0M | — | ||
| Q3 25 | $21.0M | $10.8M | ||
| Q2 25 | $21.9M | $9.6M | ||
| Q1 25 | $17.0M | $9.4M | ||
| Q4 24 | $21.4M | $7.4M | ||
| Q3 24 | $22.4M | $6.8M | ||
| Q2 24 | $20.9M | $8.5M | ||
| Q1 24 | $18.8M | $5.8M |
净利润
ACR
ASMB
| Q4 25 | $6.3M | — | ||
| Q3 25 | $18.0M | $-9.2M | ||
| Q2 25 | $4.3M | $-10.2M | ||
| Q1 25 | $-730.0K | $-8.8M | ||
| Q4 24 | $9.3M | — | ||
| Q3 24 | $8.1M | $-9.6M | ||
| Q2 24 | $6.4M | $-11.2M | ||
| Q1 24 | $4.9M | $-9.1M |
营业利润率
ACR
ASMB
| Q4 25 | 30.8% | — | ||
| Q3 25 | 85.8% | -100.9% | ||
| Q2 25 | 19.8% | -115.2% | ||
| Q1 25 | -3.8% | -105.5% | ||
| Q4 24 | 43.4% | — | ||
| Q3 24 | 36.4% | -160.1% | ||
| Q2 24 | 30.8% | -143.0% | ||
| Q1 24 | 26.2% | -185.5% |
净利率
ACR
ASMB
| Q4 25 | 31.6% | — | ||
| Q3 25 | 85.8% | -85.2% | ||
| Q2 25 | 19.8% | -105.9% | ||
| Q1 25 | -4.3% | -93.6% | ||
| Q4 24 | 43.5% | — | ||
| Q3 24 | 36.0% | -140.4% | ||
| Q2 24 | 30.6% | -130.7% | ||
| Q1 24 | 26.2% | -156.9% |
每股收益(稀释后)
ACR
ASMB
| Q4 25 | $-0.41 | — | ||
| Q3 25 | $1.34 | $-0.72 | ||
| Q2 25 | $-0.10 | $-1.33 | ||
| Q1 25 | $-0.80 | $-1.17 | ||
| Q4 24 | $0.51 | — | ||
| Q3 24 | $0.36 | $-1.51 | ||
| Q2 24 | $0.21 | $-1.98 | ||
| Q1 24 | $0.07 | $-1.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $83.8M | $22.5M |
| 总债务越低越好 | $1.6B | — |
| 股东权益账面价值 | $420.8M | $182.7M |
| 总资产 | $2.2B | $240.0M |
| 负债/权益比越低杠杆越低 | 3.68× | — |
8季度趋势,按日历期对齐
现金及短期投资
ACR
ASMB
| Q4 25 | $83.8M | — | ||
| Q3 25 | $40.9M | $22.5M | ||
| Q2 25 | $42.7M | $24.0M | ||
| Q1 25 | $66.0M | $23.4M | ||
| Q4 24 | $56.7M | $38.3M | ||
| Q3 24 | $70.1M | $28.5M | ||
| Q2 24 | $89.6M | $19.2M | ||
| Q1 24 | $84.6M | $18.7M |
总债务
ACR
ASMB
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.6B | — |
股东权益
ACR
ASMB
| Q4 25 | $420.8M | — | ||
| Q3 25 | $432.9M | $182.7M | ||
| Q2 25 | $425.3M | $18.1M | ||
| Q1 25 | $430.1M | $27.1M | ||
| Q4 24 | $439.1M | $33.4M | ||
| Q3 24 | $436.3M | $26.0M | ||
| Q2 24 | $434.0M | $34.7M | ||
| Q1 24 | $432.8M | $32.6M |
总资产
ACR
ASMB
| Q4 25 | $2.2B | — | ||
| Q3 25 | $1.7B | $240.0M | ||
| Q2 25 | $1.8B | $80.8M | ||
| Q1 25 | $1.8B | $99.0M | ||
| Q4 24 | $1.9B | $119.2M | ||
| Q3 24 | $2.0B | $100.3M | ||
| Q2 24 | $2.1B | $115.3M | ||
| Q1 24 | $2.1B | $119.9M |
负债/权益比
ACR
ASMB
| Q4 25 | 3.68× | — | ||
| Q3 25 | 2.76× | — | ||
| Q2 25 | 3.10× | — | ||
| Q1 25 | 2.97× | — | ||
| Q4 24 | 3.12× | — | ||
| Q3 24 | 3.43× | — | ||
| Q2 24 | 3.67× | — | ||
| Q1 24 | 3.79× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.1M | $-15.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-15.2M |
| 自由现金流率自由现金流/营收 | — | -140.7% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | 0.65× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ACR
ASMB
| Q4 25 | $4.1M | — | ||
| Q3 25 | $-9.4M | $-15.1M | ||
| Q2 25 | $11.8M | $-16.8M | ||
| Q1 25 | $-4.6M | $-23.4M | ||
| Q4 24 | $19.4M | $-51.1M | ||
| Q3 24 | $8.4M | $-15.2M | ||
| Q2 24 | $6.9M | $-17.1M | ||
| Q1 24 | $3.3M | $-18.4M |
自由现金流
ACR
ASMB
| Q4 25 | — | — | ||
| Q3 25 | — | $-15.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-17.1M | ||
| Q1 24 | — | $-18.4M |
自由现金流率
ACR
ASMB
| Q4 25 | — | — | ||
| Q3 25 | — | -140.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -695.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -200.6% | ||
| Q1 24 | — | -317.7% |
资本支出强度
ACR
ASMB
| Q4 25 | — | — | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.2% |
现金转化率
ACR
ASMB
| Q4 25 | 0.65× | — | ||
| Q3 25 | -0.52× | — | ||
| Q2 25 | 2.72× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.08× | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | 1.07× | — | ||
| Q1 24 | 0.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACR
| Other | $10.8M | 54% |
| Pacmulti JVLLC | $5.2M | 26% |
| Mccallum Jv Llc | $2.5M | 12% |
| Office Complex | $1.5M | 7% |
ASMB
暂无分部数据